Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Diabetologia|May 1, 2009
Combined analysis of 19 common validated type 2 diabetes susceptibility gene variants shows moderate discriminative value and no evidence of gene-gene interactionT Sparsø, N Grarup, C Andreasen, et al.
Diabetologia|June 24, 2008
Impact of polymorphisms in WFS1 on prediabetic phenotypes in a population-based sample of middle-aged people with normal and abnormal glucose regulationT Sparsø, G Andersen, A Albrechtsen, et al.
Diabetes/Metabolism Research and Reviews|December 29, 2016
Cardiovascular risk factors and incident albuminuria in screen-detected type 2 diabetesD R Webb, F Zaccardi, M J Davies, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 13, 2015
The role of serum methylglyoxal on diabetic peripheral and cardiovascular autonomic neuropathy: the ADDITION Denmark studyC S Hansen, T M Jensen, J S Jensen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|June 18, 2011
Screening for type 2 diabetes. Lessons from the ADDITION-Europe studyM van den Donk, A Sandbaek, K Borch-Johnsen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 10, 2015
Cost-effectiveness of intensive multifactorial treatment compared with routine care for individuals with screen-detected Type 2 diabetes: analysis of the ADDITION-UK cluster-randomized controlled trialL Tao, E C F Wilson, N J Wareham, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|June 13, 2020
Patient-reported outcomes after 10-year follow-up of intensive, multifactorial treatment in individuals with screen-detected type 2 diabetes: the ADDITION-Europe trialE-M Dalsgaard, A Sandbaek, S J Griffin, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 19, 2014
Does early intensive multifactorial therapy reduce modelled cardiovascular risk in individuals with screen-detected diabetes? Results from the ADDITION-Europe cluster randomized trialJ A Black, S J Sharp, N J Wareham, et al.
Diabetologia|November 17, 2007
The GCKR rs780094 polymorphism is associated with elevated fasting serum triacylglycerol, reduced fasting and OGTT-related insulinaemia, and reduced risk of type 2 diabetesT Sparsø, G Andersen, T Nielsen, et al.
Diabetologia|August 9, 2011
Homozygous carriers of the G allele of rs4664447 of the glucagon gene (GCG) are characterised by decreased fasting and stimulated levels of insulin, glucagon and glucagon-like peptide (GLP)-1S S Torekov, L Ma, N Grarup, et al.
Pageof 5